Edinburgh, Scotland (May 9, 2024) - Blackford, the pioneering strategic AI platform and solutions provider, and Thirona, expert in AI-based lung image analysis, today announced a commercial partnership to bring the LungQ™ solution to healthcare professionals via the Blackford Platform. 

Blackford provides healthcare professionals access to an extensive portfolio of more than 130 AI solutions designed to augment clinical accuracy and drive efficiency and improve patient outcomes. By integrating Thirona’s advanced technology into the Blackford Platform, Blackford can offer healthcare providers more powerful tools to support the analysis of thoracic CT scans for advancing the treatment of pulmonary diseases.

"Our partnership with Thirona exemplifies our dedication to equipping healthcare professionals with innovative AI tools.” says Ben Panter, Founder and CEO of Blackford. “By integrating Thirona's advanced technology into our platform, we are enhancing our ability to deliver comprehensive support for lung disease assessments to clinicians and their patients."

Thirona’s LungQ™ clinical software offered through the Blackford platform supports efficient workflows in diagnosis and treatment planning for COPD.

The ability to perform quantitative measurements within the identified sub-compartments on thoracic CTs aids clinicians in more accurate and precise diagnosis and timely management of the disease. Enabling personalized approach to treatment planning and monitoring of disease progression over time, automated LungQ analysis helps potentially improve patient’s outcomes, documented with objective evidence.

“Our robust technology was developed for specialized clinical trials and interventional pulmonology and has proven to deliver consistently high performance. In collaboration with integration partners like Blackford, we can make the most pivotal analysis available for clinical use, supporting clinicians in providing the best possible patient care.” says Eva van Rikxoort, CEO and Founder of Thirona.